| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |